Annual long term liabilities:
$30.86B-$1.21B(-3.78%)Summary
- As of today (August 20, 2025), GSK annual total long term liabilities is $30.86 billion, with the most recent change of -$1.21 billion (-3.78%) on December 31, 2024.
- During the last 3 years, GSK annual long term liabilities has fallen by -$15.43 billion (-33.34%).
- GSK annual long term liabilities is now -39.87% below its all-time high of $51.32 billion, reached on December 31, 2020.
Performance
GSK Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$33.61B-$234.26M(-0.69%)Summary
- As of today (August 20, 2025), GSK quarterly total long term liabilities is $33.61 billion, with the most recent change of -$234.26 million (-0.69%) on June 30, 2025.
- Over the past year, GSK quarterly long term liabilities has increased by +$3.33 billion (+11.01%).
- GSK quarterly long term liabilities is now -34.39% below its all-time high of $51.23 billion, reached on December 31, 2020.
Performance
GSK quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
GSK Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | +11.0% |
| 3 y3 years | -33.3% | -3.1% |
| 5 y5 years | -37.9% | -33.0% |
GSK Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.3% | at low | -3.1% | +11.0% |
| 5 y | 5-year | -39.9% | at low | -34.4% | +11.0% |
| alltime | all time | -39.9% | >+9999.0% | -34.4% | >+9999.0% |
GSK Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $33.61B(-0.7%) |
| Mar 2025 | - | $33.84B(+9.5%) |
| Dec 2024 | $30.86B(-3.8%) | $30.91B(-0.4%) |
| Sep 2024 | - | $31.03B(+2.5%) |
| Jun 2024 | - | $30.28B(-5.8%) |
| Mar 2024 | - | $32.13B(+0.3%) |
| Dec 2023 | $32.07B(-1.6%) | $32.05B(+1.6%) |
| Sep 2023 | - | $31.55B(-1.5%) |
| Jun 2023 | - | $32.03B(-2.6%) |
| Mar 2023 | - | $32.87B(+0.3%) |
| Dec 2022 | $32.60B(-29.6%) | $32.77B(-4.2%) |
| Sep 2022 | - | $34.21B(-1.4%) |
| Jun 2022 | - | $34.70B(-3.3%) |
| Mar 2022 | - | $35.87B(-22.3%) |
| Dec 2021 | $46.29B(-9.8%) | $46.17B(-0.8%) |
| Sep 2021 | - | $46.55B(-1.0%) |
| Jun 2021 | - | $47.03B(-7.4%) |
| Mar 2021 | - | $50.76B(-0.9%) |
| Dec 2020 | $51.32B(+3.2%) | $51.23B(+3.9%) |
| Sep 2020 | - | $49.29B(-1.7%) |
| Jun 2020 | - | $50.14B(+3.8%) |
| Mar 2020 | - | $48.30B(-2.2%) |
| Dec 2019 | $49.72B(+22.0%) | $49.39B(+1.0%) |
| Sep 2019 | - | $48.89B(+10.1%) |
| Jun 2019 | - | $44.40B(-1.3%) |
| Mar 2019 | - | $45.00B(+10.7%) |
| Dec 2018 | $40.74B(+14.3%) | $40.63B(-14.6%) |
| Sep 2018 | - | $47.58B(-1.0%) |
| Jun 2018 | - | $48.08B(+33.7%) |
| Mar 2018 | - | $35.97B(+1.0%) |
| Dec 2017 | $35.64B(-18.1%) | $35.61B(+0.1%) |
| Sep 2017 | - | $35.58B(+9.5%) |
| Jun 2017 | - | $32.50B(-25.5%) |
| Mar 2017 | - | $43.62B(+0.5%) |
| Dec 2016 | $43.53B(-5.0%) | $43.39B(-8.9%) |
| Sep 2016 | - | $47.61B(+0.9%) |
| Jun 2016 | - | $47.18B(-3.5%) |
| Mar 2016 | - | $48.90B(+6.5%) |
| Dec 2015 | $45.81B(+30.9%) | $45.91B(-2.3%) |
| Sep 2015 | - | $47.02B(+0.4%) |
| Jun 2015 | - | $46.82B(+2.4%) |
| Mar 2015 | - | $45.73B(+30.8%) |
| Dec 2014 | $35.00B(+2.3%) | $34.96B(+11.8%) |
| Sep 2014 | - | $31.26B(-7.5%) |
| Jun 2014 | - | $33.79B(-1.7%) |
| Mar 2014 | - | $34.36B(+0.7%) |
| Dec 2013 | $34.21B(+0.2%) | $34.11B(-1.9%) |
| Sep 2013 | - | $34.78B(+2.8%) |
| Jun 2013 | - | $33.84B(-4.2%) |
| Mar 2013 | - | $35.33B(+3.8%) |
| Dec 2012 | $34.15B(+26.5%) | $34.02B(+8.2%) |
| Sep 2012 | - | $31.45B(+4.0%) |
| Jun 2012 | - | $30.24B(+13.2%) |
| Mar 2012 | - | $26.70B(-0.4%) |
| Dec 2011 | $27.00B(-13.2%) | $26.80B(-14.3%) |
| Sep 2011 | - | $31.27B(+18.3%) |
| Jun 2011 | - | $26.42B(-3.4%) |
| Mar 2011 | - | $27.36B(+2.0%) |
| Dec 2010 | $31.11B | $26.81B(-18.2%) |
| Sep 2010 | - | $32.76B(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $32.18B(+1.1%) |
| Mar 2010 | - | $31.82B(-1.5%) |
| Dec 2009 | $32.27B(+7.6%) | $32.30B(+10.4%) |
| Sep 2009 | - | $29.26B(-6.0%) |
| Jun 2009 | - | $31.12B(+3.4%) |
| Mar 2009 | - | $30.08B(-0.6%) |
| Dec 2008 | $30.01B(+40.1%) | $30.28B(-1.6%) |
| Sep 2008 | - | $30.77B(-6.6%) |
| Jun 2008 | - | $32.93B(+39.6%) |
| Mar 2008 | - | $23.59B(+10.2%) |
| Dec 2007 | $21.42B(+26.7%) | $21.39B(+69.4%) |
| Sep 2007 | - | $12.63B(-1.8%) |
| Jun 2007 | - | $12.86B(-0.3%) |
| Mar 2007 | - | $12.89B(-23.8%) |
| Dec 2006 | $16.91B(+24.8%) | $16.91B(+27.5%) |
| Sep 2006 | - | $13.26B(-0.5%) |
| Jun 2006 | - | $13.33B(+2.0%) |
| Mar 2006 | - | $13.06B(-3.7%) |
| Dec 2005 | $13.54B(+7.3%) | $13.57B(+4.0%) |
| Sep 2005 | - | $13.05B(+0.3%) |
| Jun 2005 | - | $13.01B(+19.0%) |
| Mar 2005 | - | $10.93B(-11.2%) |
| Dec 2004 | $12.62B(+1.7%) | $12.31B(-3.7%) |
| Sep 2004 | - | $12.78B(+3.4%) |
| Jun 2004 | - | $12.36B(+22.1%) |
| Mar 2004 | - | $10.13B(-18.2%) |
| Dec 2003 | $12.41B(+62.5%) | $12.38B(+4.1%) |
| Sep 2003 | - | $11.89B(+0.6%) |
| Jun 2003 | - | $11.82B(+20.5%) |
| Mar 2003 | - | $9.81B(+28.1%) |
| Dec 2002 | $7.64B(+60.9%) | $7.66B(-11.3%) |
| Sep 2002 | - | $8.64B(-53.9%) |
| Jun 2002 | - | $18.71B(+158.5%) |
| Mar 2002 | - | $7.24B(+53.7%) |
| Dec 2001 | $4.75B(+18.6%) | $4.71B(-8.5%) |
| Sep 2001 | - | $5.15B(+3.4%) |
| Jun 2001 | - | $4.98B(-5.2%) |
| Mar 2001 | - | $5.25B(-0.8%) |
| Dec 2000 | $4.00B(-59.6%) | $5.29B(-5.7%) |
| Sep 2000 | - | $5.61B(-4.0%) |
| Jun 2000 | - | $5.85B(-3.6%) |
| Mar 2000 | - | $6.07B(+90.5%) |
| Dec 1999 | $9.91B(+142.3%) | $3.18B(-11.5%) |
| Jun 1999 | - | $3.60B(-10.6%) |
| Dec 1998 | $4.09B(-5.7%) | $4.02B(-9.4%) |
| Jun 1998 | - | $4.44B(+0.8%) |
| Dec 1997 | $4.34B(-13.3%) | $4.41B(-10.4%) |
| Dec 1996 | $5.00B(+12.6%) | $4.92B(-29.3%) |
| Dec 1995 | $4.44B(+851.8%) | - |
| Jun 1995 | - | $6.95B(+642.4%) |
| Jun 1994 | $466.35M(-46.5%) | $936.62M(+3.3%) |
| Jun 1993 | $871.16M(-4.1%) | $906.73M(+0.5%) |
| Jun 1992 | $908.41M(+29.1%) | $902.50M(+27.9%) |
| Jun 1991 | $703.92M(+43.7%) | $705.66M(+44.1%) |
| Jun 1990 | $489.78M(+7.9%) | $489.78M(+7.9%) |
| Jun 1989 | $454.09M(+36.3%) | $454.09M(+36.3%) |
| Jun 1988 | $333.23M(+13.1%) | $333.23M(+13.1%) |
| Jun 1987 | $294.62M(+33.7%) | $294.62M(+33.7%) |
| Jun 1986 | $220.39M(+58.4%) | $220.39M |
| Jun 1985 | $139.14M(+33.2%) | - |
| Jun 1984 | $104.45M | - |
FAQ
- What is GSK plc annual total long term liabilities?
- What is the all time high annual long term liabilities for GSK plc?
- What is GSK plc annual long term liabilities year-on-year change?
- What is GSK plc quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for GSK plc?
- What is GSK plc quarterly long term liabilities year-on-year change?
What is GSK plc annual total long term liabilities?
The current annual long term liabilities of GSK is $30.86B
What is the all time high annual long term liabilities for GSK plc?
GSK plc all-time high annual total long term liabilities is $51.32B
What is GSK plc annual long term liabilities year-on-year change?
Over the past year, GSK annual total long term liabilities has changed by -$1.21B (-3.78%)
What is GSK plc quarterly total long term liabilities?
The current quarterly long term liabilities of GSK is $33.61B
What is the all time high quarterly long term liabilities for GSK plc?
GSK plc all-time high quarterly total long term liabilities is $51.23B
What is GSK plc quarterly long term liabilities year-on-year change?
Over the past year, GSK quarterly total long term liabilities has changed by +$3.33B (+11.01%)